Understanding COVID-Associated Coagulopathy
Lab Medicine Rounds
English - May 06, 2020 05:00 - 18 minutes - 16.8 MB - ★★★★★ - 15 ratingsMedicine Health & Fitness Science laboratory medicine healthcare pathology lab medicine rounds mayo clinic laboratories lab mayo clinic clinical dlmp morice Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Time Stamps
00:00 Podcast Intro
00:40 What is COVID-associated coagulopathy and why is it important to recognize this?
02:45 How is this coagulopathy similar to or different from other coagulopathies that we commonly see in clinical practice?
04:30 Is there recommended testing for COVID-associated coagulopathy?
06:30 Can you explain what the soluble fibrin monomer test is?
08:09 How is COVID-associated coagulopathy managed in terms on prophylactic anticoagulation, therapeutic anticoagulation, and prophylactic transfusion?
14:23 What are a few lessons that you have learned during this pandemic so far?
Resources:
1. F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19,Thrombosis Research (2020), https://doi.org/10.1016/j.thromres.2020.04.013